Informações:
Falhas:
ID
33964
Descrição
Icotinib as Adjuvant Therapy in Treating Non-small-cell Lung Cancer Patients With Positive EGFR Mutation; ODM derived from: https://clinicaltrials.gov/show/NCT01929200
Link
https://clinicaltrials.gov/show/NCT01929200
Palavras-chave
Versões (1)
- 09/01/2019 09/01/2019 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
9 de janeiro de 2019
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Non-small-cell Lung Cancer NCT01929200
Eligibility Non-small-cell Lung Cancer NCT01929200
- StudyEvent: Eligibility
Similar models
Eligibility Non-small-cell Lung Cancer NCT01929200
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Informed Consent
Item
the patients signed the written informed consent
boolean
C0021430 (UMLS CUI [1])
Non-Small Cell Lung Carcinoma Operable TNM clinical staging | EGFR Exon 19 Mutation | EGFR Exon 21 Mutation
Item
the patients present with operable stage ii-iiia non-small-cell lung cancers with 19 or 21 exon mutation
boolean
C0007131 (UMLS CUI [1,1])
C0205188 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
C4289656 (UMLS CUI [2])
C4289654 (UMLS CUI [3])
C0205188 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
C4289656 (UMLS CUI [2])
C4289654 (UMLS CUI [3])
Cancer treatment Absent | Chemotherapy Absent | Therapeutic radiology procedure Absent
Item
the patients have no history of anti-cancer therapies including chemotherapy, radiation therapy
boolean
C0920425 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0392920 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C1522449 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0332197 (UMLS CUI [1,2])
C0392920 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C1522449 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
ECOG performance status
Item
the patients' eastern cooperative oncology group scores are ≤ 0-2
boolean
C1520224 (UMLS CUI [1])
Neoplasm Unresected
Item
patients with unresected tumor
boolean
C0027651 (UMLS CUI [1,1])
C2986425 (UMLS CUI [1,2])
C2986425 (UMLS CUI [1,2])
EGFR gene Wild Type
Item
wild egfr type
boolean
C1414313 (UMLS CUI [1,1])
C1883559 (UMLS CUI [1,2])
C1883559 (UMLS CUI [1,2])
Hypersensitivity Investigational New Drugs
Item
allergic to the study drug
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,2])
Disease Severe | Exception Malignant Neoplasms
Item
patients have severe non-cancerous diseases
boolean
C0012634 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0006826 (UMLS CUI [2,2])
C0205082 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0006826 (UMLS CUI [2,2])
Cancer treatment | Study Subject Participation Status
Item
patients are undergoing current administration of anti-cancer therapies, or are attending some other clinical trials
boolean
C0920425 (UMLS CUI [1])
C2348568 (UMLS CUI [2])
C2348568 (UMLS CUI [2])